68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

NCT06852820 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer
Hepatocellular Carcinoma
Metastatic Liver Cancer

Interventions

DRUG: Lu-PSMA-617

Sponsor

Melissa Lumish

Collaborators

[object Object]